BIOMARIN PHARMACEUTICAL INC Lease Obligation Incurred
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Lease Obligation Incurred of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2013-02-26
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for the quarter ending 2012-06-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for the quarter ending 2011-06-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for the quarter ending 2011-03-31 was $366.00K.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for fiscal 2011 was $286.00K, a 78.22% decline from fiscal 2010.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for fiscal 2010 was $1.31M.
- BIOMARIN PHARMACEUTICAL INC lease obligation incurred for fiscal 2009 was $0.00, a 100.00% decline from fiscal 2008.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 12 month |
|---|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-02-26 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $0.00 10-Q · filed 2012-04-30 | ||
| 2011-12-31 | $286.00K 10-K · filed 2013-02-26 | ||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $366.00K 10-Q · filed 2012-08-02 | |
| 2011-03-31 | $366.00K 10-Q · filed 2012-04-30 | ||
| 2010-12-31 | $1.31M 10-K · filed 2013-02-26 | ||
| 2009-12-31 | $0.00 10-K · filed 2012-02-22 | ||
| 2008-12-31 | $546.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |